Satoru Shigeno

Publication Activity (10 Years)

Years Active: 2024-2024
Publications (10 Years): 13

Top Topics

Molecular Docking

Multidrug Resistant

Mesenchymal Stem Cells

Crystal Structure

Top Venues

Antimicrobial agents and chemotherapy

The Journal of antibiotics

This page only lists publications with an associated author ORCID identifier.

Publications

Satoru Shigeno, Miyu Kadowaki, Kenichiro Nagai, Kanji Hosoda, Takeshi Terahara, Tomoyasu Nishimura, Naoki Hasegawa, Hiroshi Tomoda, Taichi Ohshiro
New polycyclic tetramate macrolactams with antimycobacterial activity produced by marine-derived Streptomyces sp. KKMA-0239. The Journal of antibiotics 77 (5) (2024)
Kanji Hosoda, Nobuhiro Koyama, Satoru Shigeno, Tomoyasu Nishimura, Naoki Hasegawa, Akihiko Kanamoto, Taichi Ohshiro, Hiroshi Tomoda
Mavintramycin A is a promising antibiotic for treating Mycobacterium avium complex infectious disease. Antimicrobial agents and chemotherapy 68 (3) (2024)
Kanji Hosoda, Nobuhiro Koyama, Satoru Shigeno, Tomoyasu Nishimura, Naoki Hasegawa, Akihiko Kanamoto, Taichi Ohshiro, Hiroshi Tomoda
Mavintramycin A is a promising antibiotic for treating Mycobacterium avium complex infectious disease. Antimicrobial agents and chemotherapy 68 (3) (2024)
Kanji Hosoda, Nobuhiro Koyama, Satoru Shigeno, Tomoyasu Nishimura, Naoki Hasegawa, Akihiko Kanamoto, Taichi Ohshiro, Hiroshi Tomoda
Mavintramycin A is a promising antibiotic for treating Mycobacterium avium complex infectious disease. Antimicrobial agents and chemotherapy (2024)
Kanji Hosoda, Nobuhiro Koyama, Satoru Shigeno, Tomoyasu Nishimura, Naoki Hasegawa, Akihiko Kanamoto, Taichi Ohshiro, Hiroshi Tomoda
Mavintramycin A is a promising antibiotic for treating Mycobacterium avium complex infectious disease. Antimicrobial agents and chemotherapy 68 (3) (2024)
Kanji Hosoda, Nobuhiro Koyama, Satoru Shigeno, Tomoyasu Nishimura, Naoki Hasegawa, Akihiko Kanamoto, Taichi Ohshiro, Hiroshi Tomoda
Mavintramycin A is a promising antibiotic for treating Mycobacterium avium complex infectious disease. Antimicrobial agents and chemotherapy 68 (3) (2024)
Satoru Shigeno, Miyu Kadowaki, Kenichiro Nagai, Kanji Hosoda, Takeshi Terahara, Tomoyasu Nishimura, Naoki Hasegawa, Hiroshi Tomoda, Taichi Ohshiro
New polycyclic tetramate macrolactams with antimycobacterial activity produced by marine-derived Streptomyces sp. KKMA-0239. The Journal of antibiotics 77 (5) (2024)
Kanji Hosoda, Nobuhiro Koyama, Satoru Shigeno, Tomoyasu Nishimura, Naoki Hasegawa, Akihiko Kanamoto, Taichi Ohshiro, Hiroshi Tomoda
Mavintramycin A is a promising antibiotic for treating Mycobacterium avium complex infectious disease. Antimicrobial agents and chemotherapy 68 (3) (2024)
Satoru Shigeno, Miyu Kadowaki, Kenichiro Nagai, Kanji Hosoda, Takeshi Terahara, Tomoyasu Nishimura, Naoki Hasegawa, Hiroshi Tomoda, Taichi Ohshiro
New polycyclic tetramate macrolactams with antimycobacterial activity produced by marine-derived Streptomyces sp. KKMA-0239. The Journal of antibiotics (2024)
Keisuke Kobayashi, Rio Tejima, Kenichiro Nagai, Reiko Seki, Tsuyoshi Hosoya, Yumi Une, Satoru Shigeno, Hiroshi Tomoda, Taichi Ohshiro
Paranazzamides A and B, new cyclic dipeptides containing a C7-prenylated tryptophan, produced by pathogenic reptile fungi Paranannizziopsis sp. UH-21. The Journal of antibiotics 77 (7) (2024)
Kanji Hosoda, Nobuhiro Koyama, Satoru Shigeno, Tomoyasu Nishimura, Naoki Hasegawa, Akihiko Kanamoto, Taichi Ohshiro, Hiroshi Tomoda
Mavintramycin A is a promising antibiotic for treating Mycobacterium avium complex infectious disease. Antimicrobial agents and chemotherapy 68 (3) (2024)
Keisuke Kobayashi, Rio Tejima, Kenichiro Nagai, Reiko Seki, Tsuyoshi Hosoya, Yumi Une, Satoru Shigeno, Hiroshi Tomoda, Taichi Ohshiro
Paranazzamides A and B, new cyclic dipeptides containing a C7-prenylated tryptophan, produced by pathogenic reptile fungi Paranannizziopsis sp. UH-21. The Journal of antibiotics (2024)
Kanji Hosoda, Nobuhiro Koyama, Satoru Shigeno, Tomoyasu Nishimura, Naoki Hasegawa, Akihiko Kanamoto, Taichi Ohshiro, Hiroshi Tomoda
Mavintramycin A is a promising antibiotic for treating Mycobacterium avium complex infectious disease. Antimicrobial agents and chemotherapy 68 (3) (2024)